Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing cilostazol vs aspirin for prevention of recurrent cerebral infarction
jRCT1080220034Phase 4Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cilostazol in brain infarction and ischemic stroke (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Prevention of recurrent stroke. Started Sep 2005; status: completed.
02
Drugs
cilostazol
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on jRCT1080220034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220034.